Sunnymeath Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-20
Closed -$2K 161
2016
Q3
$2K Buy
+20
New +$2.17K ﹤0.01% 112

Other funds holding CELG

Sunnymeath Asset Management's CELG Position: Q4 2016 in Review

Sunnymeath Asset Management increased its Celgene Corp (CELG) stake by 5.9% in Q4 2016, buying an estimated $89.1K and bringing the position to 14,325 shares worth $1.66M. The position accounts for 2.33% of the portfolio, ranked #7.

Sunnymeath Asset Management first reported a position in CELG in Q4 2015 and has held it in 5 quarters since. The position peaked at $1.84M in Q4 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Sunnymeath Asset Management held 14,325 shares of Celgene Corp worth $1.66M as of Q4 2016.
  • Sunnymeath Asset Management bought 800 Celgene Corp shares in Q4 2016, an estimated $89.1K.
  • Celgene Corp made up 2.33% of Sunnymeath Asset Management's portfolio in Q4 2016, its #7 holding.
  • Sunnymeath Asset Management first reported a position in Celgene Corp in Q4 2015 and has held it in 5 quarters since.
  • Sunnymeath Asset Management's Celgene Corp position peaked at $1.84M in Q4 2015.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.